Related Experiment Video
Updated: May 16, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Year in diabetes 2012: The diabetes tsunami
1Department of Internal Medicine, Division of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. robert.sherwin@yale.edu
The Journal of Clinical Endocrinology and Metabolism
|November 28, 2012
Summary
Diabetes is a growing global health crisis. Early detection and improved interventions are crucial to manage its impact and protect individuals from type 1 and type 2 diabetes.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Biomedical Research
Background:
- Diabetes mellitus affects over 300 million people globally, causing significant morbidity and mortality.
- The increasing incidence and prevalence of diabetes necessitate better understanding of its biological mechanisms and improved prevention/treatment strategies.
- Current treatment options for type 2 diabetes (T2DM), especially in obese children, have limitations, and reversing new-onset type 1 diabetes remains challenging.
Purpose of the Study:
- To highlight the escalating global diabetes crisis and the urgent need for enhanced prevention and treatment strategies.
- To discuss recent advancements and potential future directions in diabetes research, including early detection and novel therapeutic targets.
- To emphasize the importance of individualized care and early intervention for managing diabetes and its complications.
Main Methods:
- Review of current guidelines from major diabetes associations (ADA/EASD, Endocrine Society).
- Analysis of recent clinical trial data on prediabetes, T2DM, and type 1 diabetes.
- Exploration of emerging research areas including the central nervous system's role, novel hormones, and β-cell imaging techniques.
Main Results:
- Restoring normal glucose metabolism in prediabetes may delay T2DM progression.
- Immunotherapy shows potential in delaying β-cell function loss in new-onset type 1 diabetes.
- Emerging research identifies potential new therapeutic targets and early detection biomarkers for obesity and T2DM.
Conclusions:
- A global 'diabetes tsunami' is imminent, requiring robust early warning systems and improved interventions.
- Individualized care and early detection are key to mitigating the impact of diabetes.
- Novel research avenues offer promise for more effective diabetes management and prevention.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...